BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Lytix Biopharma 

P.O. Box 6447
Tromso Research Park
Tromso    N-9294  Norway
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Lytix Biopharma and KAEL–GemVax Announce First Patient Treated in Clinical Trial to Combine LTX-315 and GV1001 Cancer Vaccine Immunotherapy 12/6/2010 11:50:35 AM    More...
Lytix Biopharma Announces Approval by Hungarian Authorities and Ethics Committee to Start Phase IIa Clinical Trial with LytixarTM (LTX-109) in Gram Positive Skin Infections 9/1/2010 8:21:28 AM    More...
Lytix Biopharma and KAEL–GemVax announce approval of joint clinical trial to combine LTX-315 and GV1001 cancer vaccine immunotherapy 6/8/2010 10:54:48 AM    More...
Lytix Biopharma Announces Regulatory Approval by Swedish Authorities to Commence Phase I/IIa Clinical Trial with LytixarTM (LTX-109) in MRSA 5/24/2010 10:47:24 AM    More...
Lytix Biopharma as Update on Phase I Progress with Oncopore(TM) for Solid Tumors 5/20/2010 10:53:58 AM    More...
Lytix Biopharma Announces Regulatory Approval by Norwegian and Swedish Authorities to Commence Phase I Clinical Trial of Oncopore(TM) (LTX-315) in Cancer 12/15/2009 9:07:16 AM    More...
Lytix Biopharma Closes $10.4 Million Funding Round 1/22/2009 6:18:43 AM    More...
Lytix Biopharma Presents LTX-109 Anti-Microbial Data at ICAAC Novel Antimicrobial Drug Demonstrates Ultra-Rapid Effectiveness Against Broad Range of Drug-Resistant Pathogens 11/20/2008 10:57:36 AM    More...
Lytix Biopharma Reveals Further Details on First Cancer Candidate Oncopore at BIO 2008 6/17/2008 10:58:00 AM    More...
Lytix Biopharma to Take Lead Cancer Compound into Clinic 3/31/2008 11:46:53 AM    More...
12

//-->